Study Enrollment

Your details will not be published or shared.

Clinical Trial

(Gel) A Two-part, Multicenter, Dose-titration Study Evaluating the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Oxybutynin Chloride 10% Gel for the Treatment of Detrusor Overactivity Associated With a Neurological Condition in Pediatric Patients

The intent of this study is to see if oxybutynin chloride gel is safe and effective in treating/managing detrusor bladder over-activity in children.

Eligibility Criteria

  • Age 3 to 16 years of age Have a diagnosis of detrusor overractivity

Contact Information

    Kimberly Hekl

    (706) 721-0193